Predict your next investment

SUMGEN company logo
HEALTHCARE | Drug Development
sumgenbio.com

See what CB Insights has to offer

Founded Year

2015

Stage

Series B | Alive

Total Raised

$39.64M

Last Raised

$32.3M | 1 yr ago

About SUMGEN

SUMGEN is an antibody drug developer.

SUMGEN Headquarter Location

Room 301, 3rd Floor, Building 2, Binan Road No.688, Changhe Street Binjiang District

Hangzhou, Zhejiang ,

China

0571-87961799

Latest SUMGEN News

Sumgen Completes $32 Million Round for Immunotherapy Antibodies

Oct 1, 2020

publication date: Oct 1, 2020 Sumgen Biotech of Hangzhou completed a $32 million Series B funding round to advance its portfolio of novel immunotherapy antibodies. The round was led by Addor Capital and co-led by Cowin Capital and Sinowisdom Investment. The proceeds will be used to fund clinical trials of the company's pipeline of ten oncology mAbs and construction of an antibody production facility in Hangzhou Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SUMGEN

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SUMGEN is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

SUMGEN Patents

SUMGEN has filed 3 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/11/2019

Clusters of differentiation, Monoclonal antibodies, Immunology, Transcription factors, Immune system

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/11/2019

00/00/0000

00/00/0000

Grant Date

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Clusters of differentiation, Monoclonal antibodies, Immunology, Transcription factors, Immune system

Subscribe to see more

Subscribe to see more

Status

Application

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.